e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
Tremblay A., Mason C., Michaud G., van der Giessen L. J., Gosselink R., Hop W. C. J., Tiddens H. A. W. M.
Source:
Eur Respir J 2007; 30: 763-768
Journal Issue:
October
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tremblay A., Mason C., Michaud G., van der Giessen L. J., Gosselink R., Hop W. C. J., Tiddens H. A. W. M.. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?. Eur Respir J 2007; 30: 763-768
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis
Source: Eur Respir J 2002; 19: 294-302
Year: 2002
RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis
Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Year: 2006
α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Source: Eur Respir J 2007; 29: 240-250
Year: 2007
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis
Source: Eur Respir J 2011; 37: 1091-1095
Year: 2011
Effects of DNase on pulmonary function and exercise capacity in cystic fibrosis (CF)
Source: Eur Respir J 2001; 18: Suppl. 33, 127s
Year: 2001
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Source: Eur Respir J 2002; 20: 122-126
Year: 2002
The oral AntibioticS approprIateness score (OASIS) – A novel scoring system to assess antibiotic route in pulmonary exacerbations of cystic fibrosis (CF)
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Supressive antimicrobial therapy in chronic bronchial infection: the example of cystic fibrosis
Source: Annual Congress 2011 - Chronic bronchial infection: more than a syndrome
Year: 2011
Reporting specific airway resistance (sRaw) in children: mean or median?
Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006
Year: 2006
The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis
Source: Eur Respir J 2011; 37: 806-812
Year: 2011
The prevalence and characteristics of intravenous (IV) antibiotics allergy in adult patient with cystic fibrosis (CF)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice
Source: Eur Respir J 2011; 37: 72-78
Year: 2011
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011
Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash?
Source: Eur Respir J 2011; 37: 757-759
Year: 2011
New insights into the pathophysiology of lung disease in cystic fibrosis patients
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1
Year: 2006
Combination of inhaled corticosteroids and long acting beta two agonists improve lung clearance index (LCI) in preschoolers with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the
G551D-CFTR
mutation treated with ivacaftor: A secondary analysis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Gene therapy for cystic fibrosis: successes and challenges
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=79
Year: 2006
Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis
Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept